Breaking Updates in Hematological-Oncology

The American Society of Hematology (ASH) 2020 Annual Meeting and Exposition was held on the 5–8 December.

Despite the pandemic, the virtual format showcased outstanding leaps in understanding and treatment in 2020, across malignancies.

Explore our coverage by disease type, including updates from key trials in which new agents are moving forwards.

View all videos

ASH 2020

American Society of Hematology (ASH) Annual Meeting and Exposition
5–8 December 2020

#iwNHL21: Scott J. Rodig discusses checkpoint inhibitors

Click here for the in latest #Lymphoma: https://tinyurl.com/LymphomaNews

#Lymsm #NonHodgkinLymphoma @VJHemOnc

#iwNHL21: Francisco J. Hernandez-Ilizaliturri discusses IMiDs in combination

Click here for the in latest #Lymphoma: https://tinyurl.com/LymphomaNews

#Lymsm #NonHodgkinLymphoma @VJHemOnc

#iwNHL21: Frederick Locke discusses how tumor IFN signaling and suppressive myeloid cells impact CAR T-cell efficacy

Click here for the in latest #Lymphoma: https://tinyurl.com/LymphomaNews

#Lymsm #NonHodgkinLymphoma @VJHemOnc

#iwNHL21: Stephen Ansell discusses CBT in specific lymphoma subtypes

Click here for the in latest #Lymphoma: https://tinyurl.com/LymphomaNews

#Lymsm #NonHodgkinLymphoma @VJHemOnc

#iwNHL21: Patricia Pérez Galán discusses the microenvironment in FL pathogenesis and therapy

Click here for the in latest #Lymphoma: https://tinyurl.com/LymphomaNews

#Lymsm #NonHodgkinLymphoma @VJHemOnc

Load More...

ASH 2020

American Society of Hematology (ASH) Annual Meeting and Exposition
5–8 December 2020

Breaking Updates in Hematological-Oncology

The American Society of Hematology (ASH) 2020 Annual Meeting and Exposition was held on the 5–8 December.

Despite the pandemic, the virtual format showcased outstanding leaps in understanding and treatment in 2020, across malignancies.

Explore our coverage by disease type, including updates from key trials in which new agents are moving forwards.

View all videos

#iwNHL21: Scott J. Rodig discusses checkpoint inhibitors

Click here for the in latest #Lymphoma: https://tinyurl.com/LymphomaNews

#Lymsm #NonHodgkinLymphoma @VJHemOnc

#iwNHL21: Francisco J. Hernandez-Ilizaliturri discusses IMiDs in combination

Click here for the in latest #Lymphoma: https://tinyurl.com/LymphomaNews

#Lymsm #NonHodgkinLymphoma @VJHemOnc

#iwNHL21: Frederick Locke discusses how tumor IFN signaling and suppressive myeloid cells impact CAR T-cell efficacy

Click here for the in latest #Lymphoma: https://tinyurl.com/LymphomaNews

#Lymsm #NonHodgkinLymphoma @VJHemOnc

#iwNHL21: Stephen Ansell discusses CBT in specific lymphoma subtypes

Click here for the in latest #Lymphoma: https://tinyurl.com/LymphomaNews

#Lymsm #NonHodgkinLymphoma @VJHemOnc

#iwNHL21: Patricia Pérez Galán discusses the microenvironment in FL pathogenesis and therapy

Click here for the in latest #Lymphoma: https://tinyurl.com/LymphomaNews

#Lymsm #NonHodgkinLymphoma @VJHemOnc

Load More...

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter